A NOVEL STRATEGY FOR THE INVESTIGATION OF CLONALITY IN PRECANCEROUS DISEASE STATES AND EARLY STAGES OF TUMOR PROGRESSION

Citation
M. Sternlicht et al., A NOVEL STRATEGY FOR THE INVESTIGATION OF CLONALITY IN PRECANCEROUS DISEASE STATES AND EARLY STAGES OF TUMOR PROGRESSION, Biochemical and biophysical research communications, 199(2), 1994, pp. 511-518
Citations number
20
Categorie Soggetti
Biology,Biophysics
ISSN journal
0006291X
Volume
199
Issue
2
Year of publication
1994
Pages
511 - 518
Database
ISI
SICI code
0006-291X(1994)199:2<511:ANSFTI>2.0.ZU;2-D
Abstract
A novel strategy for clonality determination from only 100 cells using the polymerase chain reaction in amplifying a 511 bp region located w ithin the first intron of the human hypoxanthine phosphoribosyl transf erase (HPRT) gene has been devised. The strategy rests on several obse rvations: that this region in females contains two HpaII/MspI sites wh ose methylation remains both obligate with X chromosome inactivation a nd independent of tumor progression; and that this region contains sin gle base allelic polymorphisms in 5-10% of females which can be detect ed by denaturing gradient gel electrophoresis (DGGE) on the PCR produc t. In polymorphic individuals, multiple bands (homo- and heteroduplexe s) indicate multiclonality, single bands indicate monoclonality, and t heir comparative migrations indicate clonal identity/non-identity. (C) 1994 Academic Press, Inc.